AARTIPHARM — Aarti Pharmalabs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹75.57bn
- IN₹79.16bn
- IN₹21.15bn
- 73
- 21
- 72
- 59
Annual cashflow statement for Aarti Pharmalabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | Interim Report | ARS | ARS | ARS |
| Standards: | — | — | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.046 | 1,554 | 2,608 | 3,005 | 3,607 |
| Depreciation | |||||
| Non-Cash Items | — | 103 | 217 | 245 | 417 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.046 | -2,515 | -950 | -1,818 | -1,577 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0 | -437 | 2,501 | 2,164 | 3,316 |
| Capital Expenditures | — | -1,412 | -1,197 | -1,988 | -4,439 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 24.1 | -381 | -158 | 300 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -1,387 | -1,578 | -2,146 | -4,139 |
| Financing Cash Flow Items | — | -120 | -211 | -172 | -245 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | 2,604 | -1,635 | 97.2 | 654 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 779 | -712 | 115 | -169 |